Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana L Blithe

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Contraception|March 9, 2019
Acceptability of the Woman's Condom in a phase III multicenter open-label studyBeatrice A Chen, Diana L Blithe, Gitonga R Muraguri, et al.
Contraception|June 22, 2021
Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept studyVivian Brache, Carolina Sales Vieira, Marlena Plagianos, et al.
Obstetrics and Gynecology|September 4, 2007
Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trialKurt T Barnhart, Michael J Rosenberg, H Trent MacKay, et al.
Plos One|June 5, 2024
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal ringsSharon L Achilles, Clifton W Kelly, Craig J Hoesley, et al.
Journal of Clinical Pharmacology|August 26, 2018
FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications"Mohammad Akbar, Erin Berry-Bibee, Diana L Blithe, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in MenSherry Wu, Fiona Yuen, Ronald S Swerdloff, et al.
Contraception|August 6, 2019
Comparison of self-reported female condom failure and biomarker-confirmed semen exposureTerri L Walsh, Margaret C Snead, Breione J St Claire, et al.
The Lancet. Global Health|June 25, 2019
Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trialsDavid F Archer, Ruth B Merkatz, Luis Bahamondes, et al.
Fertility and Sterility|October 12, 2024
Use of at-home sperm concentration testing in a male hormonal contraceptive efficacy clinical trialChristina Wang, Yanhe Lue, Ronald S Swerdloff, et al.
NEJM Evidence|July 22, 2025
Contraceptive Efficacy and Comparative Side Effects of a Mini Copper Intrauterine DeviceCourtney A Schreiber, Kavita Nanda, David Hubacher, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Contraception|March 9, 2019
Acceptability of the Woman's Condom in a phase III multicenter open-label studyBeatrice A Chen, Diana L Blithe, Gitonga R Muraguri, et al.
Contraception|June 22, 2021
Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept studyVivian Brache, Carolina Sales Vieira, Marlena Plagianos, et al.
Obstetrics and Gynecology|September 4, 2007
Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trialKurt T Barnhart, Michael J Rosenberg, H Trent MacKay, et al.
Plos One|June 5, 2024
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal ringsSharon L Achilles, Clifton W Kelly, Craig J Hoesley, et al.
Journal of Clinical Pharmacology|August 26, 2018
FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications"Mohammad Akbar, Erin Berry-Bibee, Diana L Blithe, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in MenSherry Wu, Fiona Yuen, Ronald S Swerdloff, et al.
Contraception|August 6, 2019
Comparison of self-reported female condom failure and biomarker-confirmed semen exposureTerri L Walsh, Margaret C Snead, Breione J St Claire, et al.
The Lancet. Global Health|June 25, 2019
Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trialsDavid F Archer, Ruth B Merkatz, Luis Bahamondes, et al.
Fertility and Sterility|October 12, 2024
Use of at-home sperm concentration testing in a male hormonal contraceptive efficacy clinical trialChristina Wang, Yanhe Lue, Ronald S Swerdloff, et al.
NEJM Evidence|July 22, 2025
Contraceptive Efficacy and Comparative Side Effects of a Mini Copper Intrauterine DeviceCourtney A Schreiber, Kavita Nanda, David Hubacher, et al.
Pageof 6